Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2010 1
2011 1
2012 1
2013 2
2014 3
2015 4
2016 2
2017 8
2018 2
2019 5
2020 4
2021 3
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 2 Esophagitis, CTCAE"
Page 1
Chemoradiation for elderly patients ( 65 years) with esophageal cancer: a retrospective single-center analysis.
Linde P, Mallmann M, Adams A, Wegen S, Rosenbrock J, Trommer M, Marnitz S, Baues C, Celik E. Linde P, et al. Radiat Oncol. 2022 Nov 17;17(1):187. doi: 10.1186/s13014-022-02160-w. Radiat Oncol. 2022. PMID: 36397163 Free PMC article.
A subgroup comparison was conducted between patients aged 70 years and > 70 years. RESULTS: In severe (CTCAE Grade 3-5) toxicities (acute and late), no significant differences were observed between both patient groups (< 70 years vs. > 70 years). 21% had ac …
A subgroup comparison was conducted between patients aged 70 years and > 70 years. RESULTS: In severe (CTCAE Grade 3-5) tox …
The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.
de Jong C, Chargi N, Herder GJM, van Haarlem SWA, van der Meer F, van Lindert ASR, Ten Heuvel A, Brouwer J, de Jong PA, Devriese LA, Huitema ADR, Egberts TCG, de Bree R, Deneer VHM. de Jong C, et al. J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1554-1564. doi: 10.1002/jcsm.12967. Epub 2022 Mar 18. J Cachexia Sarcopenia Muscle. 2022. PMID: 35301821 Free PMC article.
RESULTS: In total, 297 patients (male n = 167, median age 64 years) were included. Haematological toxicity grade 3/4 was experienced in 36.6% (n = 108) of the patients, 24.6% (n = 73) experienced any non-haematological toxicity grade 2, and 55.6% (n = 165) an …
RESULTS: In total, 297 patients (male n = 167, median age 64 years) were included. Haematological toxicity grade 3/4 was experienced …
The efficacy and safety of definitive concurrent chemoradiotherapy for non-operable esophageal cancer.
Dreyfuss AD, Barsky AR, Wileyto EP, Eads JR, Kucharczuk JC, Williams NN, Karasic TB, Metz JM, Ben-Josef E, Plastaras JP, Wojcieszynski AP. Dreyfuss AD, et al. Cancer Med. 2021 Feb;10(4):1275-1288. doi: 10.1002/cam4.3724. Epub 2021 Jan 20. Cancer Med. 2021. PMID: 33474812 Free PMC article.
Most severe toxicities were acute grade 4 hematologic cytopenia (6%) and radiation dermatitis (1%). Most common acute grade 3 toxicities were hematologic cytopenia (35%), dysphagia (23%), and anorexia (19%). ...
Most severe toxicities were acute grade 4 hematologic cytopenia (6%) and radiation dermatitis (1%). Most common acute grade 3 …
Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer.
Bourbonne V, Da-Ano R, Jaouen V, Lucia F, Dissaux G, Bert J, Pradier O, Visvikis D, Hatt M, Schick U. Bourbonne V, et al. Radiother Oncol. 2021 Feb;155:144-150. doi: 10.1016/j.radonc.2020.10.040. Epub 2020 Nov 6. Radiother Oncol. 2021. PMID: 33161012
The goal of this work is to investigate the added predictive value of the radiomics approach applied to dose maps regarding acute and late toxicities in both the lungs and esophagus. METHODS: Acute and late toxicities scored using the CTCAE v4.0 were retrospectively collec …
The goal of this work is to investigate the added predictive value of the radiomics approach applied to dose maps regarding acute and late t …
Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases.
Peyraga G, Caron D, Lizee T, Metayer Y, Septans AL, Pointreau Y, Denis F, Ganem G, Lafond C, Roche S, Dupuis O. Peyraga G, et al. Support Care Cancer. 2018 Jun;26(6):1897-1903. doi: 10.1007/s00520-017-4001-4. Epub 2017 Dec 23. Support Care Cancer. 2018. PMID: 29275524
The median overall time of treatment was 13 days [3-33]. Forty patients (31.3%) suffered from grade 2 of "esophagitis" (35 grade 2 (27.4%) and 5 grade 3 (3.9%)). Eight patients (6.3%) suffered from grade 2 of "nausea and/or …
The median overall time of treatment was 13 days [3-33]. Forty patients (31.3%) suffered from grade 2 of "esophagitis" …
Continuous hyperfractionated accelerated radiotherapy - Escalated dose (CHART-ED): A phase I study.
Hatton MQ, Hill R, Fenwick JD, Morgan SA, Wilson PC, Atherton PJ, Dickson J, Murray KE, Paul J. Hatton MQ, et al. Radiother Oncol. 2016 Mar;118(3):471-7. doi: 10.1016/j.radonc.2015.11.015. Epub 2015 Dec 11. Radiother Oncol. 2016. PMID: 26687902 Free article. Clinical Trial.
Total dose was escalated from standard CHART radiotherapy of 54 Gy/36f/12 days to 57.6G y (2 1.8 Gy fractions on day 15, Group 1), 61.2 Gy (4 1.8 Gy fractions on days 15-16, Group 2) and 64.8 Gy (6 1.8 Gy fractions on days 15-17, Group 3). ...Of these 9 patie …
Total dose was escalated from standard CHART radiotherapy of 54 Gy/36f/12 days to 57.6G y (2 1.8 Gy fractions on day 15, Group 1), 61 …
Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer.
Nieder C, Imingen KS, Mannsåker B, Yobuta R, Haukland E. Nieder C, et al. Radiat Oncol. 2020 May 1;15(1):91. doi: 10.1186/s13014-020-01550-2. Radiat Oncol. 2020. PMID: 32357936 Free PMC article.
INCLUSION CRITERIA: prescribed total dose 30-54 Gy, dose per fraction 2.5-4 Gy, esophageal dose > 1 Gy. Uni- and multivariate analyses were performed in 97 eligible patients to identify predictive factors for acute esophagitis grade 1 (CTCAE …
INCLUSION CRITERIA: prescribed total dose 30-54 Gy, dose per fraction 2.5-4 Gy, esophageal dose > 1 Gy. Uni- and multivaria …
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study.
Ridolfi L, De Rosa F, Petracci E, Tanda ET, Marra E, Pigozzo J, Marconcini R, Guida M, Cappellini GCA, Gallizzi G, Occelli M, Pala L, Gambale E, Bersanelli M, Galdo G, Cortellini A, Morgese F, Zoratto F, Stucci LS, Strippoli S, Guidoboni M; Italian Melanoma Intergroup (IMI). Ridolfi L, et al. J Geriatr Oncol. 2020 Apr;11(3):515-522. doi: 10.1016/j.jgo.2019.12.012. Epub 2020 Jan 9. J Geriatr Oncol. 2020. PMID: 31928943
RESULTS: 174 patients were considered; 59.2% males, median age 79 years (range 75-93). The majority had a performance status of 0 and normal lactate dehydrogenase (LDH) levels (55.2% and 52.4%, respectively). 69.1% had multiple co-morbidities. 56.9% received nivolum …
RESULTS: 174 patients were considered; 59.2% males, median age 79 years (range 75-93). The majority had a performance status of 0 and …
Evaluation of the early adverse effects of radiotherapy in breast cancer patients with COVID-19: Prospective single institutional study.
Allali S, Servois V, Beddok A, Fourquet A, Kirova Y. Allali S, et al. Breast J. 2021 Nov;27(11):824-827. doi: 10.1111/tbj.14282. Epub 2021 Aug 25. Breast J. 2021. PMID: 34435418 Free PMC article.
Radiotherapy (RT) consisted of breast or chest wall irradiation with or without lymph node irradiation, with protocols adapted to pandemic situation. The treatment-related toxicity was graded according to the CTCAE (version 4.03). All 350 patients treated for early- …
Radiotherapy (RT) consisted of breast or chest wall irradiation with or without lymph node irradiation, with protocols adapted to pandemic s …
Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study.
Yu WW, Zhu ZF, Fu XL, Zhao KL, Mao JF, Wu KL, Yang HJ, Fan M, Zhao S, Welsh J. Yu WW, et al. Strahlenther Onkol. 2014 Oct;190(11):979-86. doi: 10.1007/s00066-014-0636-y. Epub 2014 Mar 8. Strahlenther Onkol. 2014. PMID: 24609941 Clinical Trial.
The most common grade 2 and 3 radiation-related toxicity was radiation esophagitis, occurring in 64 % of all patients (but only 13 % as grade 3). No patient developed grade > 2 pulmonary complications. CONCLUSION: SIB-IMRT is a feasibl …
The most common grade 2 and 3 radiation-related toxicity was radiation esophagitis, occurring in 64 % of all patients ( …
37 results